Schedule 13G ownership disclosure

RECURSION PHARMACEUTICALS INC CL A

Class A Common Stock · CUSIP: 75629V104

Event date: 2024-12-31

Filing-level shares
23,436,636
Percent of class
6.1%
  • BlackRock, Inc.

    Shares: 23,436,636 · Class: 6.1%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0002012383-25-001493
Form type
SCHEDULE 13G/A
Filer
BlackRock, Inc.
CIK
CIK 2012383
Filed
Feb 05, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub